Conexeu Sciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024
Cash & Equivalents	6.85	4.81	0.31
Short-Term Investments	-	0.07	-
Cash & Short-Term Investments	6.85	4.88	0.31
Cash Growth	2076.64%	1451.19%	-
Other Receivables	0	0	-
Total Trade Receivables	0	0	-
Other Current Assets	1.06	2.58	0.03
Total Current Assets	7.91	7.46	0.35
Net Property, Plant & Equipment	0.04	0.01	-
Other Intangible Assets	0.16	0.18	0.19
Long-Term Investments	0.07	-	-
Other Long-Term Assets	0.01	0.04	-
Total Assets	8.2	7.69	0.53
Accounts Payable	0.53	0.26	0.33
Accrued Expenses	-	0.08	-
Other Current Liabilities	0.48	0	0.01
Total Current Liabilities	1	0.34	0.34
Total Liabilities	1	0.34	0.44
Common Stock	0.02	0.02	0.01
Additional Paid-in Capital	15.72	11.86	0.68
Retained Earnings	-8.54	-4.52	-0.6
Shareholders' Equity	7.2	7.35	0.09
Total Liabilities & Equity	8.2	7.69	0.53
Net Cash (Debt)	6.85	4.88	0.31
Net Cash Growth	40.32%	1451.19%	-
Net Cash Per Share	0.38	0.39	0.05
Book Value	7.2	7.35	0.09
Book Value Per Share	0.40	0.58	0.01
Tangible Book Value	7.03	7.18	-0.09
Tangible Book Value Per Share	0.39	0.57	-0.01

SEC Filings: 10-K · 10-Q